27

FEB-2024

POLARIS GROUP’S AFFILIATE NANOTEIN TECHNOLOGIES LAUNCHES A REVOLUTIONARY NK CELL ACTIVATION AND EXPA

27

FEB-2024

POLARIS GROUP ANNOUNCES ITS LISTING ON THE TAIWAN STOCK EXCHANGE ON JUNE 6, 2022

27

FEB-2024

POLARIS GROUP INITIATES ROLLING SUBMISSION OF BIOLOGIC LICENSE APPLICATION (BLA) FOR ADI-PEG 20 WITH

PharmaSources Customer Service